Specifically, genome-wide association studies identified that a tyrosine-histidine change at amino acid position 402 (Y402H) in the complement factor H (CFH) gene was associated with a greater than 2 to 3-fold increased odds of AMD [10,11,12]. The gene discussed is CFH; the disease is age-related macular degeneration.